MIR4650-1

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, MIR4650-1 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated MIR4650-1 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher MIR4650-1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR4650-1 expression acts as an unfavorable survival marker, although some lineages such as LAML show a favorable association.

SKCM, UVM, and LIHC are the cancer types where MIR4650-1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
SKCMOSTertileAll0.2460.784<.00196view →
UVMOSTertileAll0.1360.919<.00163view →
LIHCDFSTertileAll0.0760.553.00263view →
LAMLDFSQuartileAll0.6080.295<.00140view →
PAADDFSTertileAll0.1200.522<.00136view →
DLBCOSTertileAll0.0530.936<.00136view →
CESCOSTertileAll0.2280.598<.00136view →
OVDFSTertileIII,IV0.4530.548.01924view →
MESODFSTertileAll0.1060.369.01618view →
KIRCDFSTertileAll0.6250.872.0396view →
KICHDFSTertileAll0.4250.847.0413view →
Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

MIR4650-1–SKCM (OS)

Kaplan–Meier survival curve for MIR4650-1 RNA-high vs -low samples in SKCM.

Open the SKCM breakdown →

Exploration